-3.20%
Today
Loading 1D prices…
Company profile
Hyperion DeFi, Inc., a DeFi company, engages in building on Hyperliquid. It operates through two segments: Ophthalmic Technology and Digital Assets. The company focuses on the long-term strategic treasury of HYPE tokens to provide simplified exposure to the Hyperliquid blockchain ecosystem. It is also developing the Optejet User Filled Device to work with various topical ophthalmic liquids, including artificial tears and lens rewetting products. The company was formerly known as Eyenovia, Inc. and changed its name to Hyperion DeFi, Inc. in July 2025. Hyperion DeFi, Inc. was founded in 2014 and is based in Dallas, Texas.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Dallas, TX, United States
Employees
9
Fiscal year end
1231
CIK
1682639
Session & valuation
Latest annual period
Deterministic peer set
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| ELTXElicio Therapeutics Inc. Common Stock | $53.9M | $0.00 | — | -$2.58 | -2.84% | Buy |
| IMMPImmutep Limited American Depositary Shares | $55M | — | — | -$0.539 | +12.12% | Hold |
| SERSerina Therapeutics Inc. Common Stock | $56.4M | $130K | -14755.38% | -$1.91 | -8.00% | Buy |
| MCRBSeres Therapeutics Inc. Common Stock | $50.3M | $789K | +721.93% | $0.64 | -1.76% | Buy |
| XLOXilio Therapeutics Inc. Common Stock | $58.8M | $43.8M | -80.05% | -$4.19 | 0.00% | Buy |